SEC Form 4 · accession 0001209191-18-060011
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James B Bucher
Officer — Sr. VP & General Counsel
Period of report
Nov 25, 2018
Accepted (ET)
Nov 27, 2018 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2018 | A | 2,000 | $9.35 | A | 3,623 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $13.24 | Nov 25, 2018 | A | 70,000 | A | — | Nov 24, 2028 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2018 in a transaction exempt under Rule 16b-3(c).
- F225% of the total number of shares subject to the option shall vest on the one-year anniversary of November 25, 2018 (the "Vesting Commencement Date") and thereafter 1/48th of the total number of shares subject to the option shall vest on the monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.